The Radcliffe Department of Medicine\u2019s Dr Betty Raman is leading a new a phase 2a clinical trial to investigate whether a drug could treat the fatigue and muscle weakness experienced by many patients who have recovered from COVID.
New research led by Associate Professor Lisa Heather has found that a drug known as molidustat, currently in clinical trials for another condition, could reduce risk of heart failure after heart attacks.
Dr Richard Tyser is this year\u2019s winner of the Bernard and Joan Marshall Early Career Investigator Prize, and Dr Jack Miller has received a runner-up award, at the British Society of Cardiovascular Research Autumn Meeting.
DPAG Postdoctoral Research Scientist Dr Xin Sun has been shortlisted in the British Heart Foundation\u2019s (BHF) annual \u2018Reflections of Research\u2019 image competition.
New research from the Heather Group has shown that in type 2 diabetes an overload of lipids reduces the heart\u2019s ability to generate energy during a heart attack, decreasing chances of recovery.
In animal models, iron deficient mothers have a greatly increased risk of having offspring with congenital heart disease (CHD). The risk of CHD can be greatly reduced if the mother is given iron supplements very early in pregnancy. Additionally, embryos from a mouse model of Down Syndrome were particularly vulnerable to the effects of maternal iron deficiency, leading to a higher risk of developing severe heart defects.
Intermediate Transition Research Fellow Dr Filipa Sim\u00f5es from The Riley Group has been interviewed by the British Heart Foundation for the BHF Alumni website, where she discusses her research career, being a woman in science and supporting underrepresented students.
The British Atherosclerosis Society's John French Memorial Lecture is named in honour of the Oxford-based pathologist, Dr John French, who made seminal observations and contributions to the field of cardiovascular pathology.
People with healthier heart structure and function appear to have better cognitive abilities, including increased capacity to solve logic problems and faster reaction times, according to a study involving University of Oxford and Queen Mary University of London (QMUL) researchers.
A large-scale genetic study, led by Oxford BHF researchers Dr Parag Gajendragadkar, clinical DPhil student, Professor Barbara Casadei and Professor Jemma Hopewell, has shed new light on common heart rhythm disturbances
A new study from the Smart group has shed light on a key regulatory step in the initiation and progression of Abdominal Aortic Aneurysm by revealing the protective role of a previously little known small protein.
Vignesh Murugesan, a Postdoctoral Researcher in Department of Physiology, Anatomy & Genetics (DPAG), describes how he found his way from the large metropolitan town of Chennai in India to studying regenerative medicine here in Oxford, via an 8 year stint in Sweden.
Professor Watkins and his team have found a new type of genetic change in the DNA of people with hypertrophic cardiomyopathy (HCM) - a silent killer amongst families that can cause sudden death in young people due to the thickening of the heart muscle.
![\"Schematic](\"https://www.cardioscience.ox.ac.uk/news/rdm-researchers-test-potential-treatment-for-fatigue-in-long-covid-patients/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n